{"chebi_id":"391960","chebi_name":"darifenacin","chebi_synonyms":["DARIFENACIN","2-{(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide","(S)-1-(2-(2,3-dihydro-5-benzofuranyl)ethyl)-\u03b1,\u03b1-diphenyl-3-pyrrolidineacetamide"],"diffprof_id_observed":["MTBLS2145_0001_00000029","MTBLS2406_0002_00000009","MTBLS4893_0003_00000003","MTBLS4967_0001_00000003","MTBLS5195_0001_00000001","MTBLS5195_0002_00000001","MTBLS5943_0001_00000001"],"diffprof_id_var_observed":["MTBLS2145_0001_00000029","MTBLS4893_0003_00000003"],"inchikey":"HXGBXQDTNZMWGS-RUZDIDTESA-N","inn_name":"darifenacin","iupac_name":"2-{(3<i>S</i>)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide","num_study_observed":6,"reactome_ids":["R-HSA-162582","R-HSA-372790","R-HSA-373076","R-HSA-375280","R-HSA-390648","R-HSA-500792"],"reactome_names":["Signal Transduction","Signaling by GPCR","Class A/1 (Rhodopsin-like receptors)","Amine ligand-binding receptors","Muscarinic acetylcholine receptors","GPCR ligand binding"],"study_id_observed":["MTBLS2145","MTBLS2406","MTBLS4893","MTBLS4967","MTBLS5195","MTBLS5943"],"study_id_var_observed":["MTBLS2145","MTBLS4893"],"synonym_name":"DARIFENACIN"}